Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015

Details for Mechanism ID: 12638
Country/Region: Malawi
Year: 2015
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USAID
Total Funding: $5,098,850 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $500,747
Care: TB/HIV (HVTB) $250,747
Care: Pediatric Care and Support (PDCS) $250,747
Laboratory Infrastructure (HLAB) $200,000
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $200,000
Prevention: HIV Testing and Counseling (HVCT) $367,165
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $367,165
Treatment: Adult Treatment (HTXS) $2,585,026
Treatment: Pediatric Treatment (PDTX) $377,253
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 66,642
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 19,127
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 128,120
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 119,367
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 45,257
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 45,241
HTC_TST_DSD By Test Result: Negative 2016 318,101
HTC_TST_DSD By Test Result: Positive 2016 19,884
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 337,985
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 247,487
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 90,498
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 337,985
HTC_TST_DSD Sum of Test Result disaggregates 2016 337,985
PMTCT_ARV_DSD Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 4,951
PMTCT_ARV_DSD Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 4,704
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 2,444
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 2,260
PMTCT_ARV_DSD Sum of New and Current disaggregates 2016 4,704
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 3,961
PMTCT_STAT_DSD By: Known positives at entry 2016 3,387
PMTCT_STAT_DSD By: Number of new positives identified 2016 3,596
PMTCT_STAT_DSD Number of new ANC and L&D clients 2016 61,258
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 58,195
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2016 6,983
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 66,642
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 65,113
TX_CURR_DSD Age/Sex: 1-4 Female 2016 524
TX_CURR_DSD Age/Sex: 1-4 Male 2016 483
TX_CURR_DSD Age/Sex: 5-14 Female 2016 2,446
TX_CURR_DSD Age/Sex: 5-14 Male 2016 2,472
TX_CURR_DSD Age/Sex: <1 Female 2016 65
TX_CURR_DSD Age/Sex: <1 Male 2016 54
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 63,925
TX_CURR_DSD Sum of age/sex disaggregates 2016 63,925
TX_NEW_DSD Breastfeeding status 2016 1,063
TX_NEW_DSD By Age/Sex: 1-4 Female 2016 308
TX_NEW_DSD By Age/Sex: 1-4 Male 2016 346
TX_NEW_DSD By Age/Sex: 10-14 Female 2016 247
TX_NEW_DSD By Age/Sex: 10-14 Male 2016 212
TX_NEW_DSD By Age/Sex: 15-19 Female 2016 431
TX_NEW_DSD By Age/Sex: 15-19 Male 2016 123
TX_NEW_DSD By Age/Sex: 20-24 Female 2016 1,633
TX_NEW_DSD By Age/Sex: 20-24 Male 2016 219
TX_NEW_DSD By Age/Sex: 25-49 Female 2016 7,669
TX_NEW_DSD By Age/Sex: 25-49 Male 2016 4,529
TX_NEW_DSD By Age/Sex: 5-9 Female 2016 239
TX_NEW_DSD By Age/Sex: 5-9 Male 2016 276
TX_NEW_DSD By Age/Sex: 50+ Female 2016 617
TX_NEW_DSD By Age/Sex: 50+ Male 2016 753
TX_NEW_DSD By Age/Sex: <1 Female 2016 152
TX_NEW_DSD By Age/Sex: <1 Male 2016 142
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 17,896
TX_NEW_DSD Pregnancy status 2016 3,898
TX_NEW_DSD Sum of Age/Sex disaggregates 2016 17,896
Cross Cutting Budget Categories and Known Amounts Total: $3,085,904
Human Resources for Health $2,939,310
Food and Nutrition: Policy, Tools, and Service Delivery $46,594
Renovation $100,000